Home › NDC Lookup › RxCUI directory › RxCUI 2054989

Lusutrombopag 3 MG Oral Tablet — RxCUI 2054989

RxNorm drug concept · Semantic clinical drug
RxCUI 2054989 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2054989
Official nameLusutrombopag 3 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lusutrombopag: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Mulpleta is designed as a short, timed course — just 7 days — to raise your platelet count enough to safely get through your upcoming procedure. Once the procedure is done, the goa...
  • Why do I only take this for 7 days? Will I need it again?
  • Yes, you can take Mulpleta with or without food — a meal doesn't change how well the drug works. There are no specific food restrictions associated with Mulpleta, so just take it a...
  • Can I eat normally while taking Mulpleta?
📖 Read our full Lusutrombopag guide →

🕸️ Concept Web — How Lusutrombopag 3 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lusutrombopag 3 MG Oral Tablet RxCUI 2054989

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lusutrombopag 2054984
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mulpleta 2054990
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lusutrombopag Oral Tablet 2054988
    • Lusutrombopag Oral Product 2054986
    • Lusutrombopag Pill 2054987
    • Lusutrombopag Oral Tablet [Mulpleta] 2054992
    • Mulpleta Oral Product 2054993
    • Mulpleta Pill 2054994
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lusutrombopag 3 MG SCDC · 2054985
  • Lusutrombopag Oral Tablet SCDF · 2054988
  • Lusutrombopag Oral Product SCDG · 2054986
  • Lusutrombopag Pill SCDG · 2054987

Brand-Name Concepts

  • Lusutrombopag 3 MG Oral Tablet [Mulpleta] SBD · 2054995
  • Lusutrombopag 3 MG [Mulpleta] SBDC · 2054991
  • Lusutrombopag Oral Tablet [Mulpleta] SBDF · 2054992
  • Mulpleta Oral Product SBDG · 2054993
  • Mulpleta Pill SBDG · 2054994
  • Mulpleta BN · 2054990

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 2054989 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59630-0551-07 1 DOSE PACK in 1 CARTON (59630-551-07) / 7 TABLET, FILM COA... Mulpleta SHIONOGI INC. 2018-08-27
59630-0551-77 1 DOSE PACK in 1 CARTON (59630-551-77) / 7 TABLET, FILM COA... Mulpleta SHIONOGI INC. 2018-08-27
84230-0551-07 1 DOSE PACK in 1 CARTON (84230-551-07) / 7 TABLET, FILM COA... Mulpleta VANCOCIN ITALIA SRL 2025-12-09
85320-0551-07 1 DOSE PACK in 1 CARTON (85320-551-07) / 7 TABLET, FILM COA... Mulpleta Eddingpharm (U. S. ) Inc. 2025-11-24
Observed labelers: SHIONOGI INC. (2) · Eddingpharm (U. S. ) Inc. (1) · VANCOCIN ITALIA SRL (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.